The DOI matches its Crossref record; 71 of the 72 references it cites were found in a registry or an index.
Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment
Open accessAbstract
BACKGROUND AND OBJECTIVE: Individuals with fragile X syndrome (FXS) are frequently codiagnosed with autism spectrum disorder (ASD). Most of our current knowledge about ASD in FXS comes from family surveys and small studies. The objective of this study was to examine the impact of the ASD diagnosis in a large clinic-based FXS population to better inform the care of people with FXS. METHODS: The study employed a data set populated by data from individuals with FXS seen at specialty clinics across the country. The data were collected by clinicians at the patient visit and by parent report for nonclinical and behavioral outcomes from September 7, 2012 through August 31, 2014. Data analyses were performed by using χ2 tests for association, t tests, and multiple logistic regression to examine the association between clinical and other factors with ASD status. RESULTS: Half of the males and nearly 20% of females met Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria for current ASD. Relative to the FXS-only group, the FXS with ASD (FXS+ASD) group had a higher prevalence of seizures (20.7% vs 7.6%, P < .001), persistence of sleep problems later in childhood, increased behavior problems, especially aggressive/disruptive behavior, and higher use of α-agonists and antipsychotics. Behavioral services, including applied behavior analysis, appeared to be underused in children with FXS+ASD (only 26% and 16% in prekindergarten and school-age periods, respectively) relative to other populations with idiopathic ASD. CONCLUSIONS: These findings confirm among individuals with FXS an association of an ASD diagnosis with important cooccurring conditions and identify gaps between expected and observed treatments among individuals with FXS+ASD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“50% of males, and 20% of females with Fragile X meet full diagnostic criteria for ASD (Kaufmann et al., 2017)”
From Parallel social information processing circuits are differentially impacted in autism (2020) · cites this paper as Kaufmann et al., 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
Global Prevalence of Autism and Other Pervasive Developmental Disorders
Elsabbagh, M., Divan, G., Koh, Y., Kim, Y. S., Kauchali, S., Marcín, C., Montiel‐Nava, C., Patel, V., Paula, C. S., Wang, C., et al. (2012) · Autism Research · doi:10.1002/aur.239 · Cited by 2,636
(1985) · PubMed · Cited by 1,427
Costs of Autism Spectrum Disorders in the United Kingdom and the United States
Buescher, A. V. S., Cidav, Z., Knapp, M., & Mandell, D. S. (2014) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2014.210 · Cited by 1,296
Muhle, R., Trentacoste, S. V., & Rapin, I. (2004) · Pediatrics · doi:10.1542/peds.113.5.e472 · Cited by 1,207
Fragile X Genotype Characterized by an Unstable Region of DNA
Yu, S., Pritchard, M. A., Kremer, E. J., Lynch, M., Nancarrow, J. K., Baker, E. G., Holman, K., Mulley, J. C., Warren, S. T., Schlessinger, D., et al. (1991) · Science · doi:10.1126/science.252.5009.1179 · Cited by 793
FMR1 and the fragile X syndrome: Human genome epidemiology review
Crawford, D. C., Acuña, J. M., & Sherman, S. L. (2001) · Genetics in Medicine · doi:10.1097/00125817-200109000-00006 · Cited by 711
Internet survey of treatments used by parents of children with autism.
Green, V. A., Pituch, K. A., Itchon, J., Choi, A., O’Reilly, M., & Sigafoos, J. (2006) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2004.12.002 · Cited by 617
Flagged first, then by citations
1 of the 72 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 271
Cordeiro, L., Braden, M. L., Coan, E., Welnick, N., Tanda, T., & Tartaglia, N. R. (2020) · Brain Sciences · doi:10.3390/brainsci10040248 · Cited by 16
Saraf, T. S., McGlynn, R. P., Bhatavdekar, O., Booth, R. G., & Canal, C. E. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00574 · Cited by 12
Elhawary, N. A., Tayeb, M. T., Sindi, I. A., Qutub, N. A., Rashad, M. M., Mufti, A. H., Arab, A. H., Khogeer, A., Elhawary, E. N., Dannoun, A. I., et al. (2019) · Cogent Biology · doi:10.1080/23312025.2019.1606555 · Cited by 12
Dynamic duo – FMRP and TDP-43: Regulating common targets, causing different diseases
Ferro, D., Yao, S., & Zarnescu, D. C. (2018) · Brain Research · doi:10.1016/j.brainres.2018.04.034 · Cited by 14
Rahdar, M., Davoudi, S., Dehghan, S., Javan, M., Hosseinmardi, N., Behzadi, G., & Janahmadi, M. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110057 · Cited by 11
Saldarriaga, W., Payán‐Gómez, C., González-Teshima, L. Y., Rosa, L., Tassone, F., & Hagerman, R. J. (2020) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000850 · Cited by 11
Fragile X Syndrome: Lessons Learned and What New Treatment Avenues Are on the Horizon
Hagerman, R. J., & Hagerman, P. J. (2021) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-052120-090147 · Cited by 12
Maternal Microbiota Modulate a Fragile X-like Syndrome in Offspring Mice
Varian, B. J., Weber, K. T., Kim, L. J., Chavarria, T. E., Carrasco, S. E., Muthupalani, S., Poutahidis, T., Zafarullah, M., AlOlaby, R. R., Barboza, M., et al. (2022) · Genes · doi:10.3390/genes13081409 · Cited by 11
Ketogenic Diet Affects Sleep Architecture in C57BL/6J Wild Type and Fragile X Mice
Westmark, P. R., Gholston, A. K., Swietlik, T. J., Maganti, R. K., & Westmark, C. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914460 · Cited by 12
Spontaneous seizures in adult Fmr1 knockout mice: FVB.129P2-Pde6b+ Tyr Fmr1/J
Armstrong, J. L., Saraf, T. S., Bhatavdekar, O., & Canal, C. E. (2022) · Epilepsy Research · doi:10.1016/j.eplepsyres.2022.106891 · Cited by 11
D’Addario, S. L., Rosina, E., Cenere, M. M., Bagni, C., Mercuri, N. B., & Ledonne, A. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02831-y · Cited by 9
Mosaicism in Short Tandem Repeat Disorders: A Clinical Perspective
Doss, R. M., Lopez-Ignacio, S., Dischler, A. M., Hiatt, L., Dashnow, H., Breuss, M. W., & Dias, C. (2025) · Genes · doi:10.3390/genes16020216 · Cited by 11
Descriptive analysis of seizures and comorbidities associated with fragile X syndrome
Albizua, I., Charen, K. H., Shubeck, L., Talboy, A. L., Berry‐Kravis, E., Kaufmann, W. E., Stallworth, J. L., Drazba, K., Erickson, C. A., Sweeney, J. A., et al. (2022) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.2001 · Cited by 9
Klusek, J., Will, E., Moser, C., Hills, K. J., Thurman, A. J., Abbeduto, L., & Roberts, J. E. (2023) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-023-01044-1 · Cited by 10
Aishworiya, R., Tak, Y., Ponzini, M., Biag, H., Salcedo-Arellano, M., Kim, K., Tassone, F., Schneider, A., Thurman, A., Abbeduto, L., et al. (2023) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10299 · Cited by 7
Altered brain serotonin 5-HT1A receptor expression and function in juvenile Fmr1 knockout mice
Saraf, T. S., Chen, Y., Tyagi, R., & Canal, C. E. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109774 · Cited by 9
Kieffer, F., Hilal, F. F., Gay, A.-S., Debayle, D., Pronot, M., Poupon, G., Lacagne, I., Bardoni, B., Martin, S., & Gwizdek, C. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.954087 · Cited by 9
A holistic approach to fragile X syndrome integrated guidance for person‐centred care
Johnson, K., Stanfield, A. C., Scerif, G., McKechanie, A. G., Clarke, A. J., Herring, J., Smith, K., & Crawford, H. (2024) · Journal of Applied Research in Intellectual Disabilities · doi:10.1111/jar.13214 · Cited by 9
Freitag, C. M., Chiocchetti, A. G., Haslinger, D., Yousaf, A., & Waltes, R. (2021) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917/a000803 · Cited by 11
The same stress elicits different effects on anxiety-like behavior in rat models of Fmr1 and Pten
Dey, R., & Chattarji, S. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113892 · Cited by 9
Montanaro, F. A. M., Alfieri, P., & Vicari, S. (2023) · Brain Sciences · doi:10.3390/brainsci13020277 · Cited by 9
Acamprosate rescues neuronal defects in the Drosophila model of Fragile X Syndrome
Hutson, R. L., Thompson, R. L., Bantel, A. P., & Tessier, C. R. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.01.007 · Cited by 9
Toilet Training in Fragile X Syndrome
Berry‐Kravis, E., Kidd, S. A., Lachiewicz, A. M., Choo, T. H., Tartaglia, N. R., Talapatra, D., Aguirre-Kolb, C., Andrews, H., & Riley, K. (2019) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000735 · Cited by 9
Erickson, C. A., Shaffer, R. C., Will, M., Schmitt, L., Horn, P. S., Hirst, K., Pedapati, E. V., Ober, N., Tumuluru, R. V., Handen, B. L., et al. (2023) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-023-06132-1 · Cited by 9
Westmark, P. R., Swietlik, T. J., Runde, E., Corsiga, B., Nissan, R., Boeck, B., Granger, R., Jennings, E., Nebbia, M., Thauwald, A., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126679 · Cited by 9
Lob, K., Sawka, D. M., Gaitanis, J. N., Liu, J. S.-H., & Nie, D. A. (2024) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-024-06512-1 · Cited by 8
Payne, J. M., Haebich, K. M., Mitchell, R. A., Bozaoglu, K., Giliberto, E., Lockhart, P. J., Maier, A., Velasco, S., Ball, G., North, K. N., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02863-4 · Cited by 8
Budimirovic, D. B., Cvjetković, S., Bukumirić, Z., Duy, P. Q., & Protic, D. D. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00652 · Cited by 8
Bush, L., Martin, G. E., Landau, E. B., & Losh, M. C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.718572 · Cited by 10
Malijauskaite, S., Sauer, A. K., Hickey, S., Franzoni, M., Grabrucker, A. M., & McGourty, K. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04617-3 · Cited by 8
Drosophila melanogaster as a Model to Study Fragile X-Associated Disorders
Trajković, J. Z., Makević, V., Pešić, M., Pavković‐Lučić, S., Milojević, S., Cvjetković, S., Hagerman, R. J., Budimirovic, D. B., & Protic, D. D. (2022) · Genes · doi:10.3390/genes14010087 · Cited by 8
Ranjan, R., Jha, S., Prajjwal, P., Chaudhary, A., Dudeja, P., Vora, N., Mateen, M. A., Yousuf, M. A., & Chaudhary, B. (2023) · Cureus · doi:10.7759/cureus.35505 · Cited by 8
Abbeduto, L., Soriano, L. D. H., Berry‐Kravis, E., Sterling, A. M., Edgin, J. O., Abdelnur, N., Drayton, A., Hoffmann, A., Hamilton, D., Harvey, D. J., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-36087-3 · Cited by 8
Benachenhou, S., Laroui, A., Dionne, O., Rojas, D., Toupin, A., & Çaku, A. (2023) · International review of neurobiology · doi:10.1016/bs.irn.2023.08.011 · Cited by 9
Deciphering autism heterogeneity: a molecular stratification approach in four mouse models
Gora, C., Dudas, A., Vaugrente, O., Drobecq, L., Pecnard, E., Lefort, G., & Pellissier, L. P. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03113-5 · Cited by 9
FMR1 loss in a human stem cell model reveals early changes to intrinsic membrane excitability
Susco, S. G., Arias-García, M. A., López-Huerta, V. G., Beccard, A., Bara, A. M., Moffitt, J., Korn, J. A., Fu, Z., & Barrett, L. E. (2020) · Developmental Biology · doi:10.1016/j.ydbio.2020.09.012 · Cited by 9
Abbeduto, L., Klusek, J., Taylor, J. L., Abdelnur, N., Sparapani, N., & Thurman, A. J. (2021) · Brain Sciences · doi:10.3390/brainsci11091179 · Cited by 8
Neuropsychological and ASD phenotypes in rare genetic syndromes: A critical review of the literature
Bush, L., & Scott, M. (2021) · The Clinical Neuropsychologist · doi:10.1080/13854046.2021.1980111 · Cited by 9
Tabolacci, E., Pomponi, M. G., Remondini, L., Pietrobono, R., Orteschi, D., Nobile, V., Pucci, C., Musto, E., Pane, M., Mercuri, E. M., et al. (2021) · Genes · doi:10.3390/genes12121909 · Cited by 8
Syndromic obesity with neurodevelopmental delay: Opportunities for targeted interventions
Kehinde, T. A., Bhatia, A., Olarewaju, B. A., Shoaib, M. Z., Mousa, J., & Osundiji, M. A. (2022) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2022.104443 · Cited by 8
The time is ripe for the renaissance of autism treatments: evidence from clinical practitioners
Torres, E. B., Twerski, G., Varkey, H., Rai, R., El‐Sayed, M. M., Katz, M. T., & Tarlowe, J. (2023) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2023.1229110 · Cited by 8
Mechanisms of brain overgrowth in autism spectrum disorder with macrocephaly
Currey, L., Harvey, T. J., Pelenyi, A., Piper, M., & Thor, S. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1586550 · Cited by 8
Evidence for parent-of-origin effects in autism spectrum disorder: a narrative review
Ryan, N., & Heron, E. A. (2023) · Journal of Applied Genetics · doi:10.1007/s13353-022-00742-8 · Cited by 8
Tyagi, R., Saraf, T. S., & Canal, C. E. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00137 · Cited by 7
From wings to whiskers to stem cells: why every model matters in fragile X syndrome research
Sandoval, S. O., Méndez-Albelo, N. M., Xu, Z., & Zhao, X. (2024) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-024-09545-w · Cited by 9
Javadi, S., Li, Y., Sheng, J., Zhao, L., Fu, Y., Wang, D., & Zhao, X. (2022) · BMC Medicine · doi:10.1186/s12916-022-02370-9 · Cited by 7
Ng, R., Bjornsson, H. T., Fahrner, J. A., & Harris, J. R. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.950082 · Cited by 7
Lob, K., Hou, T., Chu, T.-C., Ibrahim, N., Bartolini, L., & Nie, D.-Y. A. (2023) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2023.109228 · Cited by 7
Hoffmann, A., Thurman, A. J., Sterling, A. M., Kover, S. T., Finestack, L. H., Berry‐Kravis, E., Edgin, J. O., Drayton, A., Fombonne, E. J., & Abbeduto, L. (2022) · Brain Sciences · doi:10.3390/brainsci12050575 · Cited by 7
From Discovery to Innovative Translational Approaches in 80 Years of Fragile X Syndrome Research
van der Lei, M. B., & Kooy, R. F. (2025) · Biomedicines · doi:10.3390/biomedicines13040805 · Cited by 6
Leontiadis, L. J., Trompoukis, G., Felemegkas, P., Tsotsokou, G., Miliou, A., & Papatheodoropoulos, C. (2023) · Brain Sciences · doi:10.3390/brainsci13111598 · Cited by 6
Montanaro, F. A. M., Alfieri, P., Caciolo, C., Brunetti, A., Airoldi, A., de Florio, A., Tinella, L., Bosco, A., & Vicari, S. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03272-0 · Cited by 6
Screening for FMR1 CGG Repeat Expansion in Thai Patients with Autism Spectrum Disorder
Hnoonual, A., Jankittunpaiboon, C., & Limprasert, P. (2021) · BioMed Research International · doi:10.1155/2021/4359308 · Cited by 8
Age-Dependent Dysregulation of APP in Neuronal and Skin Cells from Fragile X Individuals
Cencelli, G., Pacini, L., Luca, A. D., Messia, I., Gentile, A., Kang, Y., Nobile, V., Tabolacci, E., Jin, P., Farace, M. G., et al. (2023) · Cells · doi:10.3390/cells12050758 · Cited by 6
Chubick, A., Wang, E., Au, C., Grody, W. W., & Ophoff, R. A. (2023) · Genes · doi:10.3390/genes14081518 · Cited by 5
Santana‐Coelho, D., & Lugo, J. N. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45110582 · Cited by 6
Nishizaki, S. S., Haghani, N. K., La, G. N., Mariano, N. A. F., Uribe‐Salazar, J. M., Kaya, G., Regester, M., Andrews, D. S., Nordahl, C. W., Amaral, D. G., et al. (2025) · Autism Research · doi:10.1002/aur.3314 · Cited by 6
Genetic Syndromes Associated with Intellectual Disabilities
Abbeduto, L., Thurman, A. J., Bullard, L., Potter, S. N., & McDuffie, A. S. (2019) · Springer eBooks · doi:10.1007/978-3-030-14895-9_13 · Cited by 6
Wilkinson, E. H., Britton, T. C., & Hall, S. S. (2022) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/1944-7558-127.6.435 · Cited by 6
Talvio, K., Minkeviciene, R., Townsley, K. G., Achuta, V. S., Huckins, L. M., Corcoran, P., Brennand, K. J., & Castrén, M. L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1034679 · Cited by 5
Ascone, F., Buzzelli, V., Mottarlini, F., Trapano, M. D., Miglioranza, P., Rava, A., Feo, A., Spano, F., Hausman, M., Sugaya, K., et al. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02361-x · Cited by 5
FMRP, a multifunctional RNA-binding protein in quest of a new identity
Khandjian, É. W., Robert, C., & Davidovic, L. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.976480 · Cited by 5
Weisz, E. D., Fenton, A. R., & Jongens, T. A. (2024) · npj Metabolic Health and Disease · doi:10.1038/s44324-024-00004-7 · Cited by 5
Unmethylated Mosaic Full Mutation Males without Fragile X Syndrome
Tak, Y., Schneider, A., Santos, E. R., Randol, J. L., Tassone, F., Hagerman, P. J., & Hagerman, R. J. (2024) · Genes · doi:10.3390/genes15030331 · Cited by 5
Randol, J. L., Kim, K., Ponzini, M. D., Tassone, F., Falcon, A. K., Hagerman, R. J., & Hagerman, P. J. (2024) · Genes · doi:10.3390/genes15030356 · Cited by 5
Therapeutic potential of GABAA receptor subunit expression abnormalities in fragile X syndrome
van der Lei, M. B., & Kooy, R. F. (2022) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2021.2008168 · Cited by 5
Development of a Quantitative FMRP Assay for Mouse Tissue Applications
Adayev, T., LaFauci, G., Xu, W., Dobkin, C., Kascsak, R. J., Brown, W. T., & Goodman, J. H. (2021) · Genes · doi:10.3390/genes12101516 · Cited by 5
Nagarathinam, I., Chong, S. S., Thelma, B. K., Margret, J. J., Venkataraman, V., Karthikeyen, N. P., & Srisailapathy, C. R. S. (2021) · Advanced Genetics · doi:10.1002/ggn2.10048 · Cited by 4
Septotemporal Variation of Information Processing in the Hippocampus of Fmr1 KO Rat
Leontiadis, L. J., Felemegkas, P., Trompoukis, G., Tsotsokou, G., Miliou, A., Karagianni, E., Rigas, P., & Papatheodoropoulos, C. (2024) · Developmental Neuroscience · doi:10.1159/000537879 · Cited by 4
Monlux, K. D., Pollard, J. S., Rodriguez, A. B., & Hall, S. S. (2021) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000001019 · Cited by 4
Protic, D. D., Salcedo‐Arellano, M. J., Stojković, M., Saldarriaga, W., Vidal, L. A. Á., Miller, R. M., Tabatadze, N., Perić, M., Hagerman, R. J., & Budimirovic, D. B. (2021) · PubMed Central · Cited by 4
Pharmacological Treatments for Fragile X Syndrome Based on Synaptic Dysfunction
Telias, M. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191102165206 · Cited by 4
FMR1 allele frequencies in 51,000 newborns: a large-scale population study in China
Zhang, J., Wu, D., Yang, R., Zhu, L., Jiang, M., Wang, W., Li, X., Jiang, X., Tong, F., & Shu, Q. (2021) · World Journal of Pediatrics · doi:10.1007/s12519-021-00473-6 · Cited by 4
Brašić, J. R., Mathur, A., & Budimirovic, D. B. (2019) · Archives of Neuroscience · doi:10.5812/ans.91831 · Cited by 4
Suresh, A., Kourdougli, N., Nomura, T., Buth, J. E., Miranda‐Rottmann, S., Sánchez-León, C. A., Wu, M. W., Nelson, S. M., Wall, L. T., Tran, A., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.04.032 · Cited by 3
Thurman, A. J., Nunnally, A. D., Nguyen, V. H., Berry‐Kravis, E., Sterling, A. M., Edgin, J. O., Hamilton, D., Aschkenasy, J. R., & Abbeduto, L. (2024) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-024-06535-8 · Cited by 3
Related Disorders (Intellectual, Attention, and Language Disorders) and ASD
Dieckhaus, M. F. S., Thomas, R. P., Frisch, M., Moreno, M. P., Suh, J., & FEIN, D. A. (2024) · Autism and child psychopathology series · doi:10.1007/978-3-031-64499-3_4 · Cited by 4
Ivarsson, M., Danielsson, H., & Imms, C. (2025) · BMC Psychology · doi:10.1186/s40359-025-02450-4 · Cited by 3
Stanfield, A. C., & McKechanie, A. G. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2510408 · Cited by 3
Zhao, S., Li, M., Chen, W., Rennie, B. J., Hsiao, Y., & Guan, Y. (2024) · Autism Research · doi:10.1002/aur.3262 · Cited by 3
Oberman, L. M., Berry‐Kravis, E., Budimirovic, D. B., Erickson, C. A., Hagerman, R. J., Harris, H. K., Hessl, D. R., Lozano, R., Thurm, A., Tartaglia, N. R., et al. (2025) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2024.0147 · Cited by 3
Adaptive Functioning Development in Infants With Agenesis of the Corpus Callosum
Haisley, L. D., Hantzsch, L., Glick, A., Turner, J., Sung, S., Swanson, M. R., Wolff, J. J., Burrows, C. A., Botteron, K. N., Dager, S. R., et al. (2025) · PEDIATRICS · doi:10.1542/peds.2024-066555 · Cited by 3
Longo, F., Aryal, S., Anastasiades, P. G., Maltese, M., Baimel, C., Albanese, F., Tabor, J., Zhu, J. D., Oliveira, M. M., Gastaldo, D., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.08.519509 · Cited by 3
Tabatadze, N., Koniashvili, O., Melikishvili, G., Bienvenu, T., Cuisset, L., Tassone, F., Protic, D. D., Naneishvili, N., Zarandia, M., Gverdtsiteli, S., et al. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1645386 · Cited by 2
Kaufmann, W. E., Horn, P. S., Budimirovic, D. B., Harris, H. K., Lozano, R., Berry‐Kravis, E., Velinov, M. T., Talboy, A. L., Sherman, S. L., Kaufmann, W. E., et al. (2025) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-025-07088-0 · Cited by 2
Möhrle, D., Ma, D., Xue, W., Yan, J., & Cheng, N. (2025) · Autism Research · doi:10.1002/aur.70152 · Cited by 3
Morphogen-guided neocortical organoids with anteroposterior areal identity
Tsai, Y., Ozaki, H., Almet, A. A., Fleming, I., Nie, C., Luo, S., Wang, X., Shiraiwa, K., Noh, M. J. M., Trejo, S., et al. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.07.014 · Cited by 7
Caffarelli, C., Santamaria, F., Mauro, D. D., Mastrorilli, C., Montella, S., Tchana, B., Valerio, G., Verrotti, A., Valenzise, M., Bernasconi, S., et al. (2018) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-018-0524-7 · Cited by 3
Decreased FMR1 mRNA levels found in men with substance use disorders
Krasteva, M. E., Koycheva, Y., Racheva, R., Taseva, T., Raycheva, T., Simeonova, S., & Andreev, B. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05270 · Cited by 2
Bekheet, M., Mansour, L. A., Elkaffas, R. H., Kamel, M. A., & Elmonem, M. A. (2023) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2023.110659 · Cited by 2
Shou, X.-Y., Zhu, Z.-W., Jin, H., Hu, J., Yan, T., Zhong, Q., Li, W., Mao, J., Dong, M.-Y., Xu, Q., et al. (2025) · World Journal of Pediatrics · doi:10.1007/s12519-025-00977-5 · Cited by 2
Berry‐Kravis, E. (2022) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/1944-7558-127.2.90 · Cited by 2
Will, E., Hills, K. J., Smith, K., McQuillin, S. D., & Roberts, J. E. (2024) · Autism · doi:10.1177/13623613231225498 · Cited by 2
Nayar, K., Bush, L., & Scott, M. (2025) · Springer eBooks · doi:10.1007/978-3-031-87228-0_2 · Cited by 2
Chloride imbalance in Fragile X syndrome
Miles, K. D., & Doll, C. A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1008393 · Cited by 1
Milojević, S., Ghosh, A., Makević, V., Stojković, M., Capovilla, M., Tosti, T. B., Budimirovic, D. B., & Protic, D. D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147949 · Cited by 1
Different faces of autism: Patients with mutations in PTEN and FMR1 genes
Gorlewicz, A., & Kanpska, E. (2024) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2024-2664 · Cited by 1
Emmitte, K. A., Peprah, P., Spitznagel, B. D., Du, Y., Nguyen, D., & Weaver, C. D. (2025) · Synlett · doi:10.1055/a-2586-6260 · Cited by 1
Kol, R., Lerner‐Geva, L., Shaham, M., Attia, O. L., Rosenbaum-Lerner, B., & Gabis, L. V. (2025) · Journal of Child Neurology · doi:10.1177/08830738251341505 · Cited by 1
Early Pragmatic Communication in Autism and Fragile X Syndrome
Hoffmann, A., Berry‐Kravis, E., & Brady, N. C. (2025) · Journal of Speech Language and Hearing Research · doi:10.1044/2025_jslhr-25-00054 · Cited by 1
Metadata
- Authors
- Kaufmann, W. E., Kidd, S. A., Andrews, H. F., Budimirovic, D. B., Esler, A., Haas-Givler, B., Stackhouse, T., Riley, C., Peacock, G., Sherman, S. L., Brown, W. T., & Berry-Kravis, E.
- Affiliations
- Boston Children's Hospital (US)
- National Fragile X Foundation (US)
- Columbia University (US)
- Kennedy Krieger Institute (US)
- University of Minnesota (US)
- Geisinger Health System, Lewisburg, Pennsylvania;
- Developmental FX, Denver, Colorado;
- Centers for Disease Control and Prevention (US)
- Emory University (US)
- New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York; and
- Departments of Pediatrics, Neurological Sciences, and Biochemistry, Rush University Medical Center, Chicago, Illinois
- Corresponding author
- Kaufmann, Walter E.
- ORCID
- Venue
- PEDIATRICS
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2017-06-01
- Volume
- 139
- Issue
- Supplement_3
- Pages
- S194-S206
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- PMC
- PMC5619699
- OpenAlex
- W2620588197
- Cited by
- 268
- References
- 72
- Citations by year
- 2026: 19 · 2025: 26 · 2024: 35 · 2023: 37 · 2022: 49 · 2021: 40 · 2020: 25 · 2019: 25 · 2018: 10 · 2017: 2
- FWCI
- 11.25
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- PEDIATRICS (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Fragile X Foundation
- National Institutes of Health (CC999999)
- Centers for Disease Control and Prevention (U01DD000231, U01DD001189, U19DD000753)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD090255)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
- Keywords
- fragile X syndrome, autism spectrum disorder, comorbidities, seizures, sleep disorders, aggression, disruptive behavior, alpha-adrenergic agonists, antipsychotic drugs, applied behavior analysis, treatment gap, sex differences
- MeSH terms
- Autism Spectrum Disorder, Applied Behavior Analysis, Adolescent, Adrenergic alpha-Agonists, Adult, Child, Child Behavior Disorders, Child, Preschool, Combined Modality Therapy, Female, Fragile X Syndrome, Humans, Infant, Longitudinal Studies, Male, Registries, Antipsychotic Agents, Comorbidity, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
